NEW METHODS OF IMMUNOHISTOCHEMICAL DIAGNOSIS OF TUMOR GROWTH

To date, questions regarding the frequency of screening, the use of markers, and diagnostic methods for cervical cancer, especially in the case of transient infection, remain open. The American Society for Colposcopy and Cervical Pathology recommends starting a cervical cancer screening program for women at age 21. In Denmark, the starting age for cervical cancer screening is 23, in France - 25, and in Finland - 30. The issue of the specifics of cervical cancer screening in women under 30 and over 30 remains controversial. To conduct an effective screening test and early diagnosis of cervical cancer, it is necessary to find methods with high specificity and sensitivity. In countries with organized cervical cancer screening based on cytological examination, a decrease in morbidity and mortality from cervical cancer has been demonstrated [1,13,14,15].